WO2014122671A3 - Compositions orales solides de saxagliptine - Google Patents

Compositions orales solides de saxagliptine Download PDF

Info

Publication number
WO2014122671A3
WO2014122671A3 PCT/IN2014/000081 IN2014000081W WO2014122671A3 WO 2014122671 A3 WO2014122671 A3 WO 2014122671A3 IN 2014000081 W IN2014000081 W IN 2014000081W WO 2014122671 A3 WO2014122671 A3 WO 2014122671A3
Authority
WO
WIPO (PCT)
Prior art keywords
saxagliptin
solid oral
oral compositions
relates
present
Prior art date
Application number
PCT/IN2014/000081
Other languages
English (en)
Other versions
WO2014122671A2 (fr
Inventor
Bandi Parthasaradhi Reddy
Podili Khadgapathi
Pvrs SUBRAHMANYAM
Original Assignee
Hetero Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation
Publication of WO2014122671A2 publication Critical patent/WO2014122671A2/fr
Publication of WO2014122671A3 publication Critical patent/WO2014122671A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

La présente invention concerne des compositions pharmaceutiques de saxagliptine. La présente invention concerne en particulier des compositions de comprimé de saxagliptine et leur procédé de préparation.
PCT/IN2014/000081 2013-02-08 2014-02-06 Compositions orales solides de saxagliptine WO2014122671A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN545/CHE/2013 2013-02-08
IN545CH2013 2013-02-08

Publications (2)

Publication Number Publication Date
WO2014122671A2 WO2014122671A2 (fr) 2014-08-14
WO2014122671A3 true WO2014122671A3 (fr) 2014-12-24

Family

ID=51300224

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000081 WO2014122671A2 (fr) 2013-02-08 2014-02-06 Compositions orales solides de saxagliptine

Country Status (1)

Country Link
WO (1) WO2014122671A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015071887A1 (fr) * 2013-11-18 2015-05-21 Ranbaxy Laboratories Limited Compositions pharmaceutiques orales de saxagliptine
WO2015071889A1 (fr) * 2013-11-18 2015-05-21 Ranbaxy Laboratories Limited Compositions orales de saxagliptine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024365A1 (en) * 2002-08-05 2006-02-02 Navin Vaya Novel dosage form
US20070172525A1 (en) * 2007-03-15 2007-07-26 Ramesh Sesha Anti-diabetic combinations
US20100074950A1 (en) * 2008-03-14 2010-03-25 Nectid Inc. Anti-diabetic combinations
US20110206766A1 (en) * 2008-04-03 2011-08-25 Boehringer Ingelheim International Gmbh Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
WO2012031124A2 (fr) * 2010-09-03 2012-03-08 Bristol-Myers Squibb Company Formulations de médicament au moyen d'antioxydants hydrosolubles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4796776A (en) 1987-02-19 1989-01-10 Northland Aluminum Products, Inc. Pressure cooker for microwave ovens
JPH0430969Y2 (fr) 1987-11-18 1992-07-27
US5229563A (en) 1990-01-11 1993-07-20 Matsushita Electric Industrial Co., Ltd. Pressure cooker
US5310981A (en) 1993-07-23 1994-05-10 Ensar Corporation Microwave cooker

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060024365A1 (en) * 2002-08-05 2006-02-02 Navin Vaya Novel dosage form
US20070172525A1 (en) * 2007-03-15 2007-07-26 Ramesh Sesha Anti-diabetic combinations
US20100074950A1 (en) * 2008-03-14 2010-03-25 Nectid Inc. Anti-diabetic combinations
US20110206766A1 (en) * 2008-04-03 2011-08-25 Boehringer Ingelheim International Gmbh Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
WO2012031124A2 (fr) * 2010-09-03 2012-03-08 Bristol-Myers Squibb Company Formulations de médicament au moyen d'antioxydants hydrosolubles

Also Published As

Publication number Publication date
WO2014122671A2 (fr) 2014-08-14

Similar Documents

Publication Publication Date Title
IL285390A (en) Arylquinazolines, their preparation and pharmaceutical preparations containing them
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12016500094A1 (en) Autotaxin inhibitors
EP3021843A4 (fr) Composés anti-viraux, compositions pharmaceutiques et méthodes d'utilisation correspondantes
WO2013134534A3 (fr) Formes à l'état solide de cabazitaxel et procédés pour les préparer
PH12016501686A1 (en) Pharmaceutical compositions of sitagliptin
WO2014203275A3 (fr) Procédé amélioré pour la préparation d'apixaban et de ses intermédiaires
WO2015092810A3 (fr) Forme amorphe d'idélalisib
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
EP3402488A4 (fr) Formes galéniques solides orales de l'eslicarbazépine
WO2014068586A3 (fr) Compositions orales solides de tolvaptan
IL246406A0 (en) History of imidazopyrazinone, their preparation and pharmaceutical preparations containing them
WO2014033526A9 (fr) Compositions pharmaceutiques d'étoricoxib
HUP1300647A2 (hu) Ciklosporin A és származékainak komplexei, elõállításuk és gyógyszerészeti kompozícióik
HUP1300646A2 (en) Complexes of fulvestrant and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
IN2014CH00840A (fr)
EP3071214A4 (fr) Compositions à base de salacia, méthodes de traitement impliquant leur administration et leurs procédés de préparation
EP3318259A4 (fr) Composition pharmaceutique stable pour administration par voie orale
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
EP3284743A4 (fr) Composés d'imidazole hétérocycliques, compositions pharmaceutiques les contenant, leur procédé de préparation et utilisation
WO2016063289A3 (fr) Compositions de comprimé pharmaceutique comprenant de la rifaximine
WO2014125504A3 (fr) Compositions pharmaceutiques de fébuxostat
MX2015016603A (es) Composiciones de corticosteroides.
WO2015052568A3 (fr) Formes solides de curcumine et de dérivés de curcumine
IL239873B (en) The history of piperidinylcarbazole, their preparation and pharmaceutical preparations containing them

Legal Events

Date Code Title Description
WA Withdrawal of international application
122 Ep: pct application non-entry in european phase

Ref document number: 14749121

Country of ref document: EP

Kind code of ref document: A2